Related Experiment Video

Updated: Aug 30, 2026

A Murine Model of Group B Streptococcus Vaginal Colonization
10:19

A Murine Model of Group B Streptococcus Vaginal Colonization

Published on: November 16, 2016

[Severe late-onset group B streptococcal infection. A case report]

Roland Haase1, Frank Nagel, Wolfgang Hirsch

  • 1Zentrum für Kinderheilkunde, Universitätsklinik und Poliklinik für Kinder- und Jugendmedizin, Martin-Luther-Universität Halle-Wittenberg. roland.haase@medizin.uni-halle.de

Zeitschrift Fur Geburtshilfe Und Neonatologie
|November 6, 2003
PubMed

Insights

Late-onset Group B Streptococcus (GBS) meningitis in infants remains a challenge, as current antibiotic prophylaxis is ineffective. Maternal vaccination offers a promising new strategy for infant protection against GBS infections.

Area of Science:

  • Neonatal infectious diseases
  • Bacterial meningitis
  • Public health

Background:

  • Group B Streptococcus (GBS) causes significant neonatal infections like pneumonia, sepsis, and meningitis.
  • Peripartal antibiotic prophylaxis is standard for early-onset GBS but ineffective for late-onset disease.
  • Late-onset GBS meningitis carries a high risk of severe neurological sequelae in infants.

Observation:

  • A 3-week-old infant developed GBS meningitis with necrotizing encephalomalacia shortly after hospital discharge.
  • The infant's mother had mastitis, but maternal GBS cultures were negative, suggesting a nosocomial infection.
  • This case highlights the limitations of current GBS prevention strategies.

Findings:

  • Standard peripartal antibiotic prophylaxis does not prevent late-onset GBS infections.
  • Despite reduced early-onset GBS incidence, late-onset cases continue to pose a threat.
  • Neurological complications affect up to 40% of infants with late-onset GBS meningitis.

Implications:

  • Maternal vaccination using multivalent conjugate vaccines is a potential new strategy for passive infant protection against GBS.
  • Further research is crucial to evaluate the efficacy of GBS vaccines in preventing neonatal infections.
  • Improved monitoring and therapeutic approaches are needed for GBS meningitis management.
Abstract

Related Concept Videos

Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Streptococcal Pharyngitis01:27

Streptococcal Pharyngitis

Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.